27 May 2021
Watch this keynote presentation by, Dr. Genevieve Boland, Assistant Professor, Harvard Medical School, titled: Multi-modality approach to predicting and monitoring immunotherapy response and resistance. This talk was presented at the SelectScience® Virtual Cancer and Immunology Research Summit 2021.
Harvard Medical School
Dr. Genevieve Boland gained her Ph.D./M.D. in cell and tissue engineering at the National Institute of Health where she focused on signaling pathways in adult human mesenchymal stem cells. Boland is an Associate Professor of Surgery at Harvard Medical School, Section Head of Melanoma/Sarcoma Surgery, and Surgical Director of the Termeer Center for Targeted Therapies at the Massachusetts General Hospital.